
PHILADELPHIA (June 01, 2006) —
Dr. Michel P. Bergoeing was presented the American Vascular Association (AVA) Resident Research Prize at the 60th Vascular Annual Meeting on June 1, 2006. The Resident Research Prize is intended to motivate physicians, early in their training, to pursue their interest in research and offer the opportunity to present their research at the Vascular Annual Meeting.
Dr. Bergoeing is enrolled in the vascular surgery residency program at Washington University, St. Louis, Mo. He was chosen for the Resident Research Prize for his work in demonstrating an in vivo murine model of aortic aneurysm disease that requires cigarette smoke exposure. This new model builds upon years of prior experience with the elastase-perfused model of aortic aneurysms used in laboratories around the world. “Dr. Bergoeing has shown that this increase in aneurismal formation with tobacco smoke exposure is associated with an increase in an enzyme thought to play a critical role in human abdominal aortic aneurysm disease,” said Dr. William H. Pearce, chair of the AVA.
Dr. Bergoeing is enrolled in two-year Vascular Surgery residency program at Washington University.
The Resident Research Prize includes a $5,000 award and the opportunity to present the winner’s work at the Vascular Annual Meeting and have it published in the Journal of Vascular Surgery.
About the Society for Vascular Surgery
The Society for Vascular Surgery (SVS) is a not-for-profit medical society that seeks to advance excellence and innovation in vascular health through education, advocacy, research and public awareness. SVS is the national advocate for 2,600 vascular surgeons dedicated to the prevention and cure of vascular disease.
###